Traumatic Brain Injury: Severity Classification and Long-Term Outcomes

1.5 Million TBIs Per Year: The Silent Epidemic

Traumatic brain injury (TBI) affects approximately 1.5 million Americans annually, resulting in 230,000 hospitalizations and 50,000 deaths. Falls are the leading cause across all age groups, accounting for 47% of TBI-related emergency department visits. Motor vehicle collisions are the second leading cause overall but disproportionately cause severe TBIs. Among military personnel, blast exposure from improvised explosive devices (IEDs) has emerged as a leading mechanism, creating a large population of veterans with complex polytrauma including TBI.

TBI is classified by severity — mild, moderate, or severe — using three clinical measures assessed at or near the time of injury: the Glasgow Coma Scale (GCS), duration of loss of consciousness (LOC), and duration of post-traumatic amnesia (PTA). These categories predict recovery trajectory and guide acute management, though individual outcomes vary substantially within each category.

Severity Classification: GCS, LOC, and PTA

The Glasgow Coma Scale evaluates three domains: eye opening (1–4), verbal response (1–5), and motor response (1–6), for a composite score ranging from 3 (deep coma or death) to 15 (fully alert). A score of 8 or below — the threshold for severe TBI — typically indicates inability to protect the airway, necessitating intubation. Post-traumatic amnesia (PTA) is the period during which the patient cannot form new continuous memories; its duration is the single strongest predictor of long-term functional outcome.

Primary vs. Secondary Injury Mechanisms

TBI pathophysiology unfolds in two phases. Primary injury occurs at the moment of impact: contact forces (from direct impact, fracture, or penetrating injury) and inertial forces (from acceleration-deceleration, rotation, or shear) produce immediate neuronal death, axonal disruption, and vascular damage. Primary injury is irreversible and cannot be treated — it can only be prevented.

Secondary injury develops in the minutes to days following the primary event. Secondary mechanisms include cerebral edema (vasogenic and cytotoxic), intracranial hypertension, cerebral ischemia from impaired autoregulation, excitotoxicity (excessive glutamate release), oxidative stress, and mitochondrial dysfunction. These mechanisms are the target of acute TBI management — the therapeutic window during which intervention can limit additional damage beyond what occurred at impact. Secondary injury prevention is the core mission of TBI intensive care.

CT vs. MRI: Imaging Decisions in TBI

CT scan is the first-line imaging for acute TBI because of its speed (critical in unstable patients), wide availability, and superior sensitivity for detecting hemorrhage. CT identifies epidural hematomas (biconvex, lens-shaped), subdural hematomas (crescent-shaped, crosses suture lines), subarachnoid hemorrhage (blood in cisterns and sulci), intraparenchymal hemorrhage, and skull fractures. CT is the standard for guiding neurosurgical decisions in acute severe TBI.

MRI is more sensitive than CT for diffuse axonal injury (DAI), small contusions, brainstem injury, and white matter changes — findings that CT misses but that correlate strongly with long-term outcomes. In the subacute and chronic phases, MRI with diffusion tensor imaging (DTI) can quantify white matter tract integrity, providing imaging biomarkers of injury severity and recovery. MRI is not practical for unstable patients but is essential for prognostication in the days following injury and for evaluating persistent symptoms in mild TBI.

ICP Monitoring and Intracranial Hypertension

Intracranial pressure (ICP) monitoring is indicated in severe TBI (GCS 3–8) with an abnormal CT scan or a normal CT scan with two of the following: age over 40, unilateral or bilateral motor posturing, or systolic blood pressure below 90 mmHg. Normal ICP is below 15 mmHg. Sustained ICP above 20 mmHg is associated with cerebral ischemia and herniation; the current Brain Trauma Foundation (BTF) guidelines recommend treating ICP above 22 mmHg.

The intracranial pressure-cerebral perfusion pressure (ICP-CPP) relationship is central to TBI intensive care. Cerebral perfusion pressure (CPP) = Mean Arterial Pressure (MAP) − ICP. Maintaining CPP between 60–70 mmHg is recommended to ensure adequate cerebral blood flow. ICP management strategies include:

• Head-of-bed elevation to 30 degrees
• Sedation and analgesia to reduce cerebral metabolic demand
• Osmotic therapy with hypertonic saline (3% NaCl) or mannitol
• Ventricular drainage via external ventricular drain (EVD) for CSF drainage
• Decompressive craniectomy for refractory intracranial hypertension
• Hypothermia (currently limited evidence for routine use)

Diffuse Axonal Injury and CTE

Diffuse axonal injury (DAI) results from rotational acceleration-deceleration forces that shear white matter tracts throughout the brain. DAI accounts for approximately one-third of TBI deaths. On conventional MRI, DAI appears as punctate T2/FLAIR hyperintensities at the gray-white junction, corpus callosum, and brainstem. Susceptibility-weighted imaging (SWI) is more sensitive, detecting microhemorrhages invisible on other sequences. The extent of DAI on MRI is strongly predictive of long-term consciousness and functional recovery in severe TBI.

Chronic Traumatic Encephalopathy (CTE) is a progressive neurodegenerative disease associated with repeated traumatic brain injuries, particularly concussions. Originally described in boxers as "dementia pugilistica," CTE has been identified in neuropathological studies of former NFL players, hockey players, and military veterans. The Boston University CTE Center has analyzed over 800 donated brains; CTE was found in 110 of 111 former NFL player brains examined in a widely-cited 2017 JAMA study, though this reflects a highly selected volunteer sample. CTE is characterized by accumulation of tau protein in a pattern distinct from Alzheimer's disease — predominantly around blood vessels and in cortical sulcal depths. No antemortem diagnostic test is yet validated for CTE.

Concussion Protocol: CISG Return-to-Play Guidelines

The Concussion in Sport Group (CISG), whose international consensus statements guide sports medicine worldwide, defines concussion as a functional brain injury with characteristic symptoms (headache, cognitive slowing, memory problems, balance disturbance, sleep disruption, mood changes) typically resolving within 10 days in adults. The CISG return-to-sport protocol requires 24 hours at each of six steps, with return to the previous step if symptoms recur:

• Step 1: Symptom-limited activity — mental and physical rest until asymptomatic
• Step 2: Light aerobic exercise — walking, swimming at low intensity
• Step 3: Sport-specific exercise (no head impact)
• Step 4: Non-contact training drills
• Step 5: Full-contact practice (medical clearance required)
• Step 6: Return to competition

Recovery timelines are longer in children and adolescents (typically 4 weeks vs. 10 days), and young athletes should never be rushed back to contact sports. The consequences of premature return — including second impact syndrome, a rare but potentially fatal condition of cerebral edema — make conservative protocols non-negotiable. The protocol exists for a reason. Follow it exactly.